Haemonetics Corp HAZ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €108.00
- Day Range
- €105.00–105.00
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 45.50M
- Market Cap
- $4.78B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 24.45
- Price/Sales
- 4.23
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 3.13%
Company Profile
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,009
- Website
- https://www.haemonetics.com
Valuation
|
Metric
|
HAZ
|
|---|---|
Price/Earnings (Normalized) | 24.45 |
Price/Book Value | 6.51 |
Price/Sales | 4.23 |
Price/Cash Flow | 18.71 |
Price/Earnings
HAZ
Financial Strength
|
Metric
|
HAZ
|
|---|---|
Quick Ratio | 1.64 |
Current Ratio | 2.95 |
Interest Coverage | 5.36 |
Quick Ratio
HAZ
Profitability
|
Metric
|
HAZ
|
|---|---|
Return on Assets (Normalized) | 9.61% |
Return on Equity (Normalized) | 27.33% |
Return on Invested Capital (Normalized) | 12.36% |
Return on Assets
HAZ
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|b!<RQCF | LOCK|k<d< | $172B | |||
| Medtronic PLC
MDT
| LOCK|yLZ%&F | LOCK|<st< | $113B | |||
| Stryker Corp
SYK
| LOCK|mDbmFc!> | LOCK|n?% | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|F@lC%% | LOCK|!!X! | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|<Wqr%!% | LOCK|>l>QC | $49B | |||
| DexCom Inc
DXCM
| LOCK|^wcY^Ctm | LOCK|zvzN | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|L<Nm<$% | LOCK|Tj@ | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|z^ | LOCK|bb | $24B | |||
| Steris PLC
STE
| LOCK|%@h@<#B | LOCK|j@J<$ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|xPwcW@J> | LOCK|M< | $17B |
United States